Geely Automobile Holdings Limited - 0175.HK

0175.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
0175.HK	1.1	3.9	-7.8	13.3	77.0	81.9	-24.5	-3.8	406.4	3382.9
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 0175.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	0175.HK
name	Geely Automobile Holdings Limited
price	14.28
changes percentage	1.1331
change	0.16
day low	13.98
day high	14.38
year high	16.44
year low	7.24
market cap	143875284000
price avg 50	14.3864
price avg 200	10.9114
exchange	HKSE
volume	44956070
avg volume	78185914
open	14.04
previous close	14.12
eps	1.49
pe	9.58
earnings announcement	2025-03-18T10:59:00.000+0000
shares outstanding	10075300000
timestamp	2025-01-17 08:08:13

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 75.7%

Overall Quarterly Financial Health: 65.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	179203592000	147964647000	21.11
gross profit	27415069000	20895637000	31.20
gross profit ratio	0.15	0.14	8.33
research and development expenses	7809997000	6764846000	15.45
operating expenses	32468747000	26576498000	22.17
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	5226398000	3564246000	46.63
ebitdaratio	0.08	0.08	-3.68
operating income	-5053678000	-5680861000	11.04
operating income ratio	0.02	0.02	-31.32
net income	5308408000	5260353000	0.91
net income ratio	0.03	0.04	-16.68
eps	0.51	0.51	0.00

Overall Score of Annual Income Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 179,204 million in 2023 from 147,965 million in 2022 representing a change of 21.11%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 27,415 million in 2023 from 20,896 million in 2022 representing a change of 31.2%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 7,810 million in 2023 from 6,765 million in 2022 representing a change of 15.45%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 5,226 million in 2023 from 3,564 million in 2022 representing a change of 46.63%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 5,308 million in 2023 from 5,260 million in 2022 representing a change of 0.91%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 32,469 million in 2023 from 26,576 million in 2022 representing a change of 22.17%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to -5,054 million in 2023 from -5,681 million in 2022 representing a change of 11.04%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	107305450000	106021847000	1.21
gross profit	16167143000	16874577000	-4.19
gross profit ratio	0.15	0.16	-5.34
research and development expenses	4553383000	4819795000	-5.53
operating expenses	19114137000	19466483000	-1.81
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	3123885000	3167008000	-1.36
ebitdaratio	0.03	0.03	-2.54
operating income	-2946994000	-2591906000	-13.70
operating income ratio	-0.03	0.02	-252.38
net income	10597868000	3737680000	183.54
net income ratio	0.1	0.03	185.60
eps	1.05	0.36	191.67

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 107,305 million in 2024Q2 from 106,022 million in 2023Q4 representing a change of 1.21%. This indicates a sales growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 19,114 million in 2024Q2 from 19,466 million in 2023Q4 representing a change of -1.81%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to -2,947 million in 2024Q2 from -2,592 million in 2023Q4 representing a change of -13.7%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to 1.05 in 2024Q2 from 1.05 in 2023Q4 representing a change of 191.67%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 16,167 million in 2024Q2 from 16,875 million in 2023Q4 representing a change of -4.19%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 4,553 million in 2024Q2 from 4,820 million in 2023Q4 representing a change of -5.53%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 3,124 million in 2024Q2 from 3,167 million in 2023Q4 representing a change of -1.36%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 10,598 million in 2024Q2 from 3,738 million in 2023Q4 representing a change of 183.54%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	192597681000	157826329000	22.03
total liabilities	107446183000	81630514000	31.63
total equity	85151498000	76195815000	11.75
cash and cash equivalents	35745963000	33341339000	7.21
short term investments	0	-1912690685	100.00
long term investments	15820708000	16432020685	-3.72
total current assets	113634900000	79063913000	43.73
total non current assets	78962781000	78762416000	0.25
total current liabilities	96823927000	68953214000	40.42
total non current liabilities	10622256000	12677300000	-16.21
common stock	183807000	183686000	0.07
retained earnings	55952249000	59659108903	-6.21
total debt	8100189000	13156364000	-38.43

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 192,598 million in 2023 from 157,826 million in 2022 representing a change of 22.03%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 85,151 million in 2023 from 76,196 million in 2022 representing a change of 11.75%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 35,746 million in 2023 from 33,341 million in 2022 representing a change of 7.21%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 0 million in 2023 from -1,913 million in 2022 representing a change of 100.0%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 113,635 million in 2023 from 79,064 million in 2022 representing a change of 43.73%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 184 in 2023 from 184 in 2022 representing a change of 0.07%. This indicates an increase in ownership interest.

  Total Debt: Total Debt decreased to 8,100 million in 2023 from 13,156 million in 2022 representing a change of -38.43%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 107,446 million in 2023 from 81,631 million in 2022 representing a change of 31.63%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 96,824 million in 2023 from 68,953 million in 2022 representing a change of 40.42%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 55,952 million in 2023 from 59,659 million in 2022 representing a change of -6.21%. This indicates an accumulated losses.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	197017141000	192597681000	2.29
total liabilities	100839144000	107446183000	-6.15
total equity	96177997000	85151498000	12.95
cash and cash equivalents	41487826000	35745963000	16.06
short term investments	0	0	NaN
long term investments	32344854000	15820708000	104.45
total current assets	95097275000	113634900000	-16.31
total non current assets	101919866000	78962781000	29.07
total current liabilities	90168209000	96823927000	-6.87
total non current liabilities	10670935000	10622256000	0.46
common stock	183807000	183807000	0.00
retained earnings	64357307000	53612890000	20.04
total debt	8030562000	8100189000	-0.86

Overall Score of Quarterly Balance Sheet

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 197,017 million in 2024Q2 from 192,598 million in 2023Q4 representing a change of 2.29%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 100,839 million in 2024Q2 from 107,446 million in 2023Q4 representing a change of -6.15%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 96,178 million in 2024Q2 from 85,151 million in 2023Q4 representing a change of 12.95%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 41,488 million in 2024Q2 from 35,746 million in 2023Q4 representing a change of 16.06%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 90,168 million in 2024Q2 from 96,824 million in 2023Q4 representing a change of -6.87%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 64,357 million in 2024Q2 from 53,613 million in 2023Q4 representing a change of 20.04%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 8,031 million in 2024Q2 from 8,100 million in 2023Q4 representing a change of -0.86%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Current Assets: Total Current Assets decreased to 95,097 million in 2024Q2 from 113,635 million in 2023Q4 representing a change of -16.31%. This indicates a worsen liquidity position.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	3433954000	5327344000	-35.54
operating cash flow	22342369000	16018395000	39.48
free cash flow	7019875000	5681407000	23.56
capital expenditure	-15322494000	-10336988000	-48.23
depreciation and amortization	8202762000	8318331000	-1.39
deferred income tax	0	0	NaN
stock based compensation	646336000	1488910000	-56.59
accounts payables	0	0	NaN
inventory	-4472165000	-5303499000	15.68
acquisitions net	-1082922000	-2830769000	61.74
investments in property plant and equipment	-5711295000	-10336988000	44.75
net cash used for investing activites	-16144646000	-12130350000	-33.09
debt repayment	-6704339000	3992036000	-267.94
common stock issued	121000	8609000	-98.59
common stock repurchased	0	0	NaN
dividends paid	-1915763000	-1925145000	0.49
net cash used provided by financing activities	-2763776000	1325083000	-308.57
cash at end of period	36775293000	33341339000	10.30
accounts receivables	-2901827000	-149029008	-1847.16
cash at beginning of period	33341339000	28013995000	19.02

Overall Score of Annual Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 3,434 million in 2023 from 5,327 million in 2022 representing a change of -35.54%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 22,342 million in 2023 from 16,018 million in 2022 representing a change of 39.48%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 7,020 million in 2023 from 5,681 million in 2022 representing a change of 23.56%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -15,322 million in 2023 from -10,337 million in 2022 representing a change of -48.23%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 646 million in 2023 from 1,489 million in 2022 representing a change of -56.59%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -2,902 million in 2023 from -149 million in 2022 representing a change of -1847.16%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -1,916 million in 2023 from -1,925 million in 2022 representing a change of 0.49%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	14151902000	11643397000	21.54
free cash flow	12067920000	8193574000	47.29
capital expenditure	-2083982000	-3449823000	39.59
depreciation and amortization	2037878000	1842562000	10.60
deferred income tax	0	0	NaN
stock based compensation	1279265000	209907000	509.44
accounts receivables	0	-2901827000	100.00
accounts payables	0	0	NaN
inventory	0	-4472165000	100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-2083982000	-3449823000	39.59
net cash used for investing activites	-10070599000	-7158332000	-40.68
debt repayment	-478691000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-72402000	-1987136000	96.36
net cash used provided by financing activities	548896000	-557553000	198.45
net change in cash	41487826000	1963740000	2012.69
cash at end of period	41487826000	1963740000	2012.69
cash at beginning of period	0	32847813000	-100.00

Overall Score of Quarterly Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 41,488 million in 2024Q2 from 1,964 million in 2023Q4 representing a change of 2012.69%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 14,152 million in 2024Q2 from 11,643 million in 2023Q4 representing a change of 21.54%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 12,068 million in 2024Q2 from 8,194 million in 2023Q4 representing a change of 47.29%. This indicates an increase in cash generated after accounting for capital expenditures.

  Dividends Paid: Dividends Paid increased to -72 million in 2024Q2 from -1,987 million in 2023Q4 representing a change of 96.36%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -2,084 million in 2024Q2 from -3,450 million in 2023Q4 representing a change of 39.59%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 1,279 million in 2024Q2 from 210 million in 2023Q4 representing a change of 509.44%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q2 from -2,902 million in 2023Q4 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q4 2023 Earnings call transcript
Q4 2020 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	17.81	14.75	20.81
net income per share	0.53	0.52	0.66
operating cash flow per share	2.22	1.6	39.13
free cash flow per share	0.7	0.57	23.25
cash per share	3.55	3.13	13.45
book value per share	8.47	7.59	11.47
tangible book value per share	8.46	5.0	69.18
shareholders equity per share	8.0	7.49	6.89
interest debt per share	0.81	1.31	-38.59
market cap	76107015108.27	101004457227.56	-24.65
enterprise value	48461241108.27	80819482227.56	-40.04
pe ratio	14.34	19.2	-25.33
price to sales ratio	0.42	0.68	-37.78
pocfratio	3.41	6.31	-45.98
pfcf ratio	10.84	17.78	-39.02
pb ratio	0.95	1.34	-29.68
ptb ratio	0.95	1.34	-29.68
ev to sales	0.27	0.55	-50.49
enterprise value over ebitda	9.27	22.68	-59.11
ev to operating cash flow	2.17	5.05	-57.01
ev to free cash flow	6.9	14.23	-51.47
earnings yield	0.07	0.05	33.93
free cash flow yield	0.09	0.06	63.98
debt to equity	0.1	0.18	-42.54
debt to assets	0.04	0.08	-49.55
net debt to ebitda	-5.29	-5.66	6.60
current ratio	1.17	1.15	2.35
interest coverage	0	0	NaN
income quality	4.21	3.42	23.02
dividend yield	0.03	0.02	32.07
payout ratio	0.36	0.37	-1.39
sales general and administrative to revenue	0.07	0.08	-9.69
research and ddevelopement to revenue	0.04	0.05	-4.68
intangibles to total assets	0.0	0.16	-99.89
capex to operating cash flow	0.69	0.65	6.27
capex to revenue	0.09	0.07	22.39
capex to depreciation	1.87	1.24	50.32
stock based compensation to revenue	0.0	0.01	-64.16
graham number	9.75	9.4	3.73
roic	-0.05	-0.06	15.35
return on tangible assets	0.03	0.04	-30.92
graham net net	-3.18	-1.89	-67.80
working capital	16810973000	10110699000	66.27
tangible asset value	85117280000	50184897000	69.61
net current asset value	6188717000	-2566601000	341.13
invested capital	44195731000	68323036000	-35.31
average receivables	38551530000	32970713000	16.93
average payables	64635598500	38835131500	66.44
average inventory	13122274500	8171951500	60.58
days sales outstanding	86.99	84.84	2.54
days payables outstanding	201.3	130.86	53.83
days of inventory on hand	37.09	31.09	19.30
receivables turnover	4.2	4.3	-2.48
payables turnover	1.81	2.79	-34.99
inventory turnover	9.84	11.74	-16.18
roe	0.07	0.07	-5.83
capex per share	1.52	1.03	47.86

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 14.34 on 2023-12-31 from 19.20 on 2022-12-31, representing a change of -25.33%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.17 on 2023-12-31 from 1.15 on 2022-12-31, representing a change of 2.35%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.10 on 2023-12-31 from 0.18 on 2022-12-31, representing a change of -42.54%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
0175.HK
calendar year	2024	2023	NaN
revenue per share	10.52	10.51	0.12
net income per share	1.04	0.37	180.47
operating cash flow per share	1.39	1.15	20.23
free cash flow per share	1.18	0.81	45.69
cash per share	4.07	3.54	14.81
book value per share	9.43	8.44	11.73
tangible book value per share	9.42	5.71	65.12
shareholders equity per share	8.78	7.98	10.12
interest debt per share	0.79	0.8	-1.93
market cap	80474663698.23	76352987755.86	5.40
enterprise value	47017399698.23	48707213755.86	-3.47
pe ratio	1.9	5.11	-62.83
price to sales ratio	0.75	0.72	4.14
pocfratio	5.69	6.56	-13.28
pfcf ratio	6.67	9.32	-28.44
pb ratio	0.9	0.95	-5.32
ptb ratio	0.9	0.95	-5.32
ev to sales	0.44	0.46	-4.62
enterprise value over ebitda	15.05	15.38	-2.14
ev to operating cash flow	3.32	4.18	-20.58
ev to free cash flow	3.9	5.94	-34.46
earnings yield	0.13	0.05	169.02
free cash flow yield	0.15	0.11	39.74
debt to equity	0.09	0.1	-10.94
debt to assets	0.04	0.04	-3.08
net debt to ebitda	-10.71	-8.73	-22.69
current ratio	1.05	1.17	-10.14
interest coverage	0	0	NaN
income quality	1.34	3.12	-57.13
dividend yield	0.0	0.03	-96.54
payout ratio	0.01	0.53	-98.71
sales general and administrative to revenue	0.08	0.07	9.98
research and ddevelopement to revenue	0.04	0.05	-6.66
intangibles to total assets	0.0	0.14	-99.88
capex to operating cash flow	0.15	0.3	-50.30
capex to revenue	0.02	0.03	-40.31
capex to depreciation	1.02	1.87	-45.38
stock based compensation to revenue	0.01	0.0	502.15
graham number	14.33	8.15	75.74
roic	-0.03	-0.03	-2.25
return on tangible assets	0.05	0.02	137.57
graham net net	-2.56	-3.17	19.00
working capital	4929066000	16810973000	-70.68
tangible asset value	96143779000	57597382000	66.92
net current asset value	-5741869000	6188717000	-192.78
invested capital	32411848000	71715629000	-54.81
average receivables	39032954500	36860636500	5.89
average payables	72300514500	65649646000	10.13
average inventory	14379043000	13579905500	5.88
days sales outstanding	29.65	36.26	-18.21
days payables outstanding	84.46	59.64	41.63
days of inventory on hand	13.17	15.57	-15.42
receivables turnover	3.04	2.48	22.27
payables turnover	1.07	1.51	-29.39
inventory turnover	6.83	5.78	18.23
roe	0.12	0.05	154.70
capex per share	0.2	0.34	-40.25

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 1.90 on 2024-06-30 Q2 from 5.11 on 2023-12-31 Q4, representing a change of -62.83%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.05 on 2024-06-30 Q2 from 1.17 on 2023-12-31 Q4, representing a change of -10.14%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.09 on 2024-06-30 Q2 from 0.10 on 2023-12-31 Q4, representing a change of -10.94%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 19.05 which is higher than current price 14.28, indicates the company may be undervalued.